Related Experiment Video
Updated: Feb 6, 2026

Quadruple Immunostaining of the Olfactory Bulb for Visualization of Olfactory Sensory Axon Molecular Identity Codes
Published on: June 5, 2017
Olfactory implant: Demand for a future treatment option in patients with olfactory dysfunction
Gerold Besser1, David T Liu1, Bertold Renner2
1Department of Otorhinolaryngology and Head and Neck Surgery, Medical University of Vienna, Austria.
Limited treatments exist for olfactory dysfunction (OD). A significant portion of patients with smell loss are interested in an olfactory implant (OI) as a future therapy option.
Area of Science:
- Otolaryngology
- Neuroscience
- Biomedical Engineering
Background:
- Olfactory dysfunction (OD) significantly impacts quality of life, with limited therapeutic options available.
- Olfactory training shows benefits, but therapy-refractory cases necessitate novel treatment approaches.
- An olfactory implant (OI) is a potential future therapy, analogous to cochlear implants.
Purpose of the Study:
- To evaluate the demand for an olfactory implant (OI) among patients suffering from olfactory dysfunction (OD).
Main Methods:
- Sixty-one patients with OD underwent olfactory testing (threshold, discrimination, identification) using Sniffin' Sticks.
- Patients completed questionnaires assessing the importance of smell (IOS), olfactory disorder severity (QOD), and interest in OI.
- Correlation analysis was performed to identify factors associated with interest in OI.
Main Results:
- Approximately one-third (34.4%) of patients expressed interest in OI as a future treatment.
- Interest in OI significantly correlated with lower olfactory test scores (TDI, I), higher QOD complaint scores, and higher IOS scores (P < .05).
Conclusions:
- A notable demand for olfactory implants exists among patients with OD, particularly those with severe symptoms and low olfactory function.
- OI may become a viable option for selected patients if future developments ensure the safety of OI procedures.
Related Concept Videos
Physiology of Smell and Olfactory Pathway
The olfactory...
Olfactory Receptors: Location and Structure
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Treatment Resistant Cancers
Patient-centered Care
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

